Understanding Radiation Proctitis: New Approach Addresses the Needs of Ovarian, Colon and Prostate Cancer Patients
April 29, 2015 09:03 ET
|
PlasmaTech Biopharmaceuticals, Inc.
NEW YORK, NY --(Marketwired - April 29, 2015) - The following is a statement issued by Expert Jeffrey Davis, COO, PlasmaTech Biopharmaceuticals (NASDAQ: PTBI): Radiation Proctitis ("RP") is a term...
PlasmaTech Biopharmaceuticals Announces Closing of Upsized $7 Million Private Placement
April 24, 2015 09:03 ET
|
PlasmaTech Biopharmaceuticals, Inc.
DALLAS, TX and NEW YORK, NY--(Marketwired - April 24, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company advancing protein biologic therapies and oncology...
Ongoing Trial May Lead to Better Understanding of Oral Mucositis, a Debilitating Side Effect Affecting Many Cancer Patients
April 23, 2015 09:03 ET
|
JV Public Relations NY
NEW YORK, NY--(Marketwired - April 23, 2015) - An ongoing clinical trial at UCLA's Jonsson Comprehensive Cancer Center evaluating the use of an oral wound rinse for the management of oral...
New Breakthroughs to Avoid Shortage of Treatment for Those With Inherited COPD
April 15, 2015 09:02 ET
|
JV Public Relations NY
NEW YORK, NY--(Marketwired - April 15, 2015) - Chronic Obstructive Pulmonary Disease (COPD) is a term used to describe progressive lung diseases including emphysema, chronic bronchitis and refractory...
PlasmaTech Biopharmaceuticals Bolsters Scientific Advisory Board With Alpha-1 Expert Charlie Strange, M.D.
April 14, 2015 09:04 ET
|
PlasmaTech Biopharmaceuticals, Inc.
DALLAS, TX and NEW YORK, NY--(Marketwired - April 14, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company advancing protein biologic therapies and oncology...